|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of intangibles | |||||
| Provision for credit losses | |||||
| Stock compensation expense | |||||
| Gain (loss) on sale of securities, net | |||||
| Deferred income tax (benefit) expense | |||||
| Increase in cash surrender value of bank-owned life insurance | |||||
| Net losses from sale and write-downs of other real estate owned and other repossessed assets | |||||
| Net gains from mortgage banking | |||||
| Origination of loans held for sale | |||||
| Proceeds from sales of loans held for sale | |||||
| Net loss (gain) from sale/disposal of fixed assets | |||||
| Net change in: | |||||
| Accrued interest receivable | |||||
| Accrued interest payable | |||||
| Other assets | |||||
| Other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Proceeds from sales | |||||
| Proceeds from maturities, calls and paydowns | |||||
| Purchases | |||||
| Proceeds from sales of other investments | |||||
| Purchases of other investments | |||||
| Purchases of bank-owned life insurance | |||||
| Proceeds from sale of SBKI, net of transaction cost | |||||
| Net increase in loans and leases | |||||
| Proceeds from sale of fixed assets | |||||
| Purchases of premises and equipment | |||||
| Proceeds from sale of other real estate owned and other repossessed assets | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net increase in deposits | |||||
| Net increase (decrease) in securities sold under agreements to repurchase | |||||
| Proceeds from borrowings | |||||
| Repayment of borrowings | |||||
| Cash dividends paid | |||||
| Issuance of preferred stock of subsidiary - non-controlling interest, net of fees | |||||
| Redemption of subordinated debt | |||||
| Issuance of subordinated debt, net of issuance costs | |||||
| Issuance of common stock | |||||
| Restricted shares withheld for taxes | |||||
| Repurchases of common stock | |||||
| Net cash provided by financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid during the period for interest | |||||
| Net cash paid during the period for income taxes | |||||
| Noncash investing and financing activities: | |||||
| Recognition of operating lease assets in exchange for lease liabilities | |||||
| Acquisition of real estate through foreclosure | |||||
| Acquisition of other repossessed assets | |||||
| Financed sales of other repossessed assets | |||||
Loading...